VHCP Management as of March 31, 2011
Portfolio Holdings for VHCP Management
VHCP Management holds 13 positions in its portfolio as reported in the March 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Neurocrine Biosciences (NBIX) | 19.1 | $36M | 4.7M | 7.59 | |
| Ironwood Pharmaceuticals (IRWD) | 17.9 | $34M | 2.4M | 13.98 | |
| DURECT Corporation | 8.5 | $16M | 4.4M | 3.60 | |
| NPS Pharmaceuticals | 8.4 | $16M | 1.6M | 9.58 | |
| Chelsea Therapeutics International | 8.1 | $15M | 3.9M | 3.88 | |
| DepoMed | 7.9 | $15M | 1.5M | 10.04 | |
| Ardea Biosciences | 7.8 | $15M | 509k | 28.69 | |
| Anacor Pharmaceuticals In | 6.9 | $13M | 2.0M | 6.46 | |
| Affymax (AFFY) | 4.2 | $7.9M | 1.4M | 5.87 | |
| ACADIA Pharmaceuticals (ACAD) | 2.9 | $5.4M | 3.4M | 1.62 | |
| Novavax | 2.8 | $5.2M | 2.0M | 2.59 | |
| Inspire Pharmaceuticals | 2.7 | $5.1M | 1.3M | 3.96 | |
| Medivation | 2.7 | $5.0M | 268k | 18.64 |
